29 GHP Q3 2025 Jun25208 ombining pioneering microbiome technology with decades of research, including a collaboration with the University of Tokyo, Zurich ETH and the Luxembourg Space Agency, Astrobiome Space SARL (Astrobiome Space) focuses on enhancing human health and longevity through the power of space-based microbiome research through its advanced microbiome supplement of the same name (Astrobiome). By leveraging its unique space-enhanced probiotic strains, the firm develops innovative postbiotic products (a class of functional bioactive compounds produced during the fermentation process by probiotic bacteria) which are designed to improve the resilience of the human body and extend the lifespan. Postbiotics include various substances, such as short-chain fatty acids, peptides, exopolysaccharides, cell surface proteins, and other microbial metabolites that can have health benefits. Unlike probiotics, which are live microorganisms, postbiotics are non-living byproducts resulting from the metabolic activity of probiotics. The metabolite complex of Astrobiome is specifically formulated to reinforce the vitality and amplify the performance of those high-capacity individuals subjected to the utmost of extreme environments (such as astronauts, high performance athletes, and everyday professionals subjected to high stress work environments). Yet, regardless of activity level, Astrobiome may be of great benefit to virtually anyone who consumes it. “Our unique, all-natural formulations harness the insights gained from space experiments, resulting in enhanced properties that promote better health,” explains Managing Director, Vera Mulyani, as she elaborates on what gives the company the competitive edge. “Our products benefit from a deeply rooted, Japanese artisanal approach to production, supported by clinical test validations as well as consumers’ positive testimonials. With experiences in space technology and extreme environment access, we are offering unique solutions that evolve alongside our uncertain and changing environment.” The postbiotics of Astrobiome are unique due to its co-cultured full-spectrum metabolite complex. Scientific studies suggest that the hundreds of metabolites identified within Astrobiome are correlated with stimulating a higher level of quorum sensing. These highly sophisticated compounds demonstrate robust support for virtually all essential human life cycles and physiological processes. This level of subsistence can very well lead to the extension of the human lifespan. The interest in postbiotics arises from their potential to confer health benefits similar to or in some cases, without the challenges associated with administering live bacteria. These benefits might include modulation of the gut microbiota, enhancement of the Integrating space technologies with groundbreaking microbiome-based nutrition solutions, Astrobiome Space SARL aims to fortify the resilience and vitality of both humans and plants through its space enhanced probiotics. We learn more about this innovative process as we speak to Vera Mulyani following the firm receiving recognition in the Global Excellence Awards 2025. Space Odyssey C immune response, improvement of the intestinal barrier function, and anti-inflammatory effects. Because postbiotics do not contain live organisms, they may offer a more stable alternative to probiotics, particularly in terms of storage and shelf life, and could be safer for use in individuals with compromised immune systems. Significant partnerships with the European Space Agency (ESA), the Luxembourg Space Agency (LSA), Tokyo University, ETH Zurich, LSA, ESA, and NASA GeneLab have not only allowed for Astrobiome Space’s expansion in Europe, but have also propelled its product evolution to an exponential level, allowing the firm to refine its offerings, leveraging space research to create a truly advanced. “Our longevity microbiome supplements and products are designed to help support cellular balance and resilience in the face of chronic stress and inflammation, factors linked to neurodegenerative diseases, which alongside the obesity pandemic, these conditions contribute to today’s leading cause of death,” Vera continues. “These developments have enabled us to meet the growing need for natural solutions while facing increasingly uncertain climate conditions.” Recently, Astrobiome Space gained notable recognition for its trailblazing research and subsequent range of supplements in the Global Excellence Awards, where it picked up the coveted title of Most Innovative Microbiome Therapeutics Company 2025. Now, as the future hurtles towards us, Astrobiome Space is committed to leveraging the insights gained from space research to improve both human health and plant resilience. “By continuing our pioneering work in microbiome technology, we plan to enhance food micronutrients, ensuring that longevity access flows in a continuous loop - from the food we eat, to the cells in our body, and back to sustainable solutions for the environment,” Vera states. “Our space-enhanced microbiome technology is already used by astronauts, Olympians, athletes, mothers, and everyday professionals facing extreme stress. As we expand our research to include plant applications, we aim to foster a circular system of longevity, offering both health benefits and environmental sustainability.” Contact: Vera Mulyani Company: Astrobiome Space SARL Web Address: https://astrobiome.space
RkJQdWJsaXNoZXIy MTUyMDQwMA==